Elevated histamine content of lung lavage in human asbestosis
- 8 Downloads
- 2 Citations
Abstract
Increased histamine levels in lung lavage have been previously reported in humans with idiopathic fibrosing alveolitis and mast cell proliferation was documented on lung tissue. Similarly, mast cell proliferation has been documented in experimental asbestosis. To evaluate the relevance of these observations to human asbestosis, we performed bronchoalveolar lavage in 10 normal volunteers (group N) and 22 long-term asbestos workers from the mines and mills of Quebec. The 22 asbestos workers were evaluated by standard clinical, functional, radiographic, and gallium-67 lung uptake tests. Five did not have any abnormality suggestive of asbestosis and constituted group A. The 6 in group B were without sufficient criteria for well-established asbestosis, but their lung pressure-volume curve was rigid and67Ga lung uptake was increased; the 11 in group C had well-established asbestosis. In addition to standard parameters of BAL cellularity and biochemistry, we measured histamine levels by fluorometric method. In normals, histamine levels were 1.0 ± 0.3 ng/ml, in group A 1.25 ± 0.37 ng/ml (NS), in group B 2.26 ± 0.86 ng/ml (P < 0.05 B vs A or N), and in group C it was 2.65 ± 0.44 ng/ml (P < 0.05 C vs A or N). BAL eosinophils were absent in normals and group A, 272 ± 136/ml in group B, and 764 ± 350 in group C (P < 0.05 for groups B and C vs normals and group A), but did not correlate with histamine content of BAL. This study provides evidence of an elevated content of histamine in the bronchoalveolar milieu of patients with early and late asbestosis. This finding is of interest in relation to the potential role of the mast cell in the disease process.
Key words
Asbestosis Mast cell Histamine EosinophilPreview
Unable to display preview. Download preview PDF.
References
- 1.Agius RM, Godfrey RC, Holgate ST (1985) Mast cell and histamine content of human bronchoalveolar lavage fluid. Thorax 40:760–767PubMedGoogle Scholar
- 2.Bates DV, Macklem PT, Christie RV (1971) The normal lung: physiology and methods of study. In: Respiratory function in disease. WB Saunders, Philadelphia, pp. 11–95, 276–280Google Scholar
- 3.Bégin R, Renzetti AD, Bigler AH, Watanabe S (1975) Flow and age dependence of airway closure and dynamic compliance. J Appl Physiol 38:199–207PubMedGoogle Scholar
- 4.Bégin R, Massé S, Bureau MA (1982) Morphology and function of the airways in early asbestosis of the sheep. Am Rev Respir Dis 126:870–876PubMedGoogle Scholar
- 5.Bégin R, Cantin A, Berthiaume Y, Boileau R, Péloquin S, Massé S (1983) Airway function in lifetime nonsmoking older asbestos workers. Am J Med 75:631–638PubMedCrossRefGoogle Scholar
- 6.Bégin R, Cantin A, Drapeau G, Lamoureux G, Boctor M, Massé S, Rola-Pleszcynski M (1983) Pulmonary uptake of Gallium-67 in asbestos exposed humans and sheep. Am Rev Respir Dis 127:623–630PubMedGoogle Scholar
- 7.Bégin R, Boctor M, Bergeron D, Cantin A, Berthiaume Y, Péloquin S, Bisson G, Lamoureux G (1984) Radiographic assessment of pleuro-pulmonary disease in asbestos workers: posteroanterior, four view films and computed tomograms of the thorax. Br J Ind Med 41:373–383PubMedGoogle Scholar
- 8.Bégin R, Cantin A, Berthiaume Y, Bisson G, Lamoureux G, Rola-Pleszczynski M, Boctor M, Dalle D, Breault J, Massé S (1984) Detection of early asbestosis. ILO VIth International Pneumoconiosis Conference Monograph 2:846–867Google Scholar
- 9.Bégin R, Cantin A, Berthiaume Y, Boileau R, Bisson G, Lamoureux G, Rola-Pleszczynski M, Drapeau G, Massé S, Boctor M, Breault J, Péloquin S, Dalle D (1985) Clinical features to stage the alveolitis in asbestos workers. Am J Ind Med 8:521–536PubMedCrossRefGoogle Scholar
- 10.Bisson G, Drapeau G, Lamoureux G, Cantin A, Rola-Pleszczynski M, Bégin R (1983) Computer based quantitative analysis of Gallium-67 uptake in normal and disease lungs. Chest 84:513–517PubMedGoogle Scholar
- 11.Haslam PL, Cromwell O, Dewar A, Turner-Warwick M (1981) Evidence of increased histamine levels in lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 44:587–593PubMedGoogle Scholar
- 12.Kawanami O, Ferrans VJ, Fulmer JD, Crystal RG (1979) Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 40:717–734PubMedGoogle Scholar
- 13.Killingsworth LM, Savory J (1972) Manual nephelometric methods for immunochemical determination of immunoglobulins IgG, IgA and IgM in human serum. Clin Chem 18:335–339PubMedGoogle Scholar
- 14.Low RB, Cutroneo KR, Davis GS, Giancola MS (1983) Lavage type III procollagen Nterminal peptides in human pulmonary fibrosis and sarcoidosis. Lab Invest 48:755–759PubMedGoogle Scholar
- 15.Rohde H, Vargas L, Eckhart E, Kalbfleisch H, Bruguera M, Timpl R (1979) Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 9:451–459PubMedCrossRefGoogle Scholar
- 16.Schulman ES, Liu MC, Proud D, Macglashan DW, Lichtenstein LM, Plaut M (1985) Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis 131:230–235PubMedGoogle Scholar
- 17.Sheinman BD, Devalia JL, Davies RJ (1985) Genesis of histamine in sputum: a role for bacteria in the airflow obstruction of acute exacerbations of chronic obstructive airways disease? Thorax 40:238Google Scholar
- 18.Siegel S (1956) Nonparametric statistics. New York, McGraw Hill, pp. 195–200Google Scholar
- 19.Siraganian RP (1974) An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 57:383–394PubMedCrossRefGoogle Scholar
- 20.Wagner MMF, Edwards RE, Moncrieff CB, Wagner JC (1984) Mast cells and inhalation of asbestos in rats. Thorax 39:539–544PubMedCrossRefGoogle Scholar
- 21.Watanabe S, Watanabe K, Ohishi T, Aiba M, Kageyama K (1974) Mast cells in the rat alveolar septa undergoing fibrosis after ionizing irradiation: ultrastructure and histochemical studies. Lab Invest 31:555–567PubMedGoogle Scholar